Vaccine News and Research

Latest Vaccine News and Research

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

In São José do Rio Preto, state of São Paulo (Brazil), almost a third of the population aged 10-40 are estimated to have no antibodies against measles, according to a new study that tested 981 people in various age groups.

7 Apr 2020

Research reveals a potential 'chink in the armor' of SARS-CoV-2

The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.

6 Apr 2020

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?

6 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

The Biogerontology Research Foundation, a registered UK charity supporting and promoting aging and longevity research worldwide since 2008, today announced the publication of a paper titled "Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections" in the leading journal Aging.

6 Apr 2020

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

The world has been hit hard by coronavirus, and health services and authorities everywhere are struggling to reduce the spread, combat the disease and protect the population. Nevertheless, the pandemic will cost lives throughout the world.

6 Apr 2020

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

For 10 days last month, they lay in side-by-side isolation units in a Seattle-area hospital, tethered to oxygen and struggling to breathe as the coronavirus ravaged their lungs.

6 Apr 2020

Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

3 Apr 2020

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

Deaths of children and adolescents in China due to infectious diseases were becoming rare prior to the COVID-19 pandemic, according to a new study.

3 Apr 2020

South Australian researchers make rapid progress in developing a COVID-19 vaccine

South Australian researchers working with Oracle Cloud technology and vaccine technology developed by local company Vaxine Pty Ltd are testing a vaccine candidate against the SARS-CoV-2 coronavirus responsible for the COVID-19 pandemic.

3 Apr 2020

First genome sequences of SARS-CoV-2 viruses in Austria openly available

The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences, in close collaboration with the Medical University of Vienna.

3 Apr 2020

Australian scientists identify possible coronavirus drug

A collaborative study led by Monash University's Biomedicine Discovery Institute in Melbourne, Australia, with the Peter Doherty Institute of Infection and Immunity, has shown that an anti-parasitic drug already available around the world kills the virus within 48 hours.

3 Apr 2020

St George's, University of London focuses entire research on tackling coronavirus

St George's, University of London, the UK's specialist health university, is focusing all its ongoing research on tackling coronavirus.

3 Apr 2020

Robots can play a major role in COVID-19 battle

Robots can significantly help in the fight against the coronavirus disease (COVID-19) that is spreading across the globe. As the number of cases tops one million, and the death toll reaching 53,000, scientists race to develop a drug or vaccine for the infectious disease. Now, robots are playing a major role in this fight, improving the health and safety of individuals and patients.

2 Apr 2020

Bayreuth expert presents reliable coronavirus analyses through data assimilation

Thanks to methods used in fluid mechanics, the course of a pandemic and the effectiveness of government containment measures can be assessed promptly and accurately, and forecasts can be derived.

2 Apr 2020

Scientists find important clues to vaccine in SARS-CoV-2 genome

A new research paper published by scientists at the University of Bristol who sequenced the genome of the SARS-CoV-2 virus, which is causing the worldwide COVID-19 illness, reveals some significant findings that could help researchers working on rolling out vaccines to stop the relentless march of the virus. The study was published online on the preprint site bioRxiv in April 2020.

2 Apr 2020

Promising vaccine patch candidate for COVID-19

In a breath of fresh air, scientists from the University of Pittsburgh School of Medicine reported that they had developed a potential new vaccine against the SARS-CoV-2 virus, which is causing the current COVID-19 pandemic. The vaccine has been tested in mice. When administered through a small patch only the size of a fingertip, the vaccine was found to generate protective neutralizing antibodies against the virus, in adequate quantities.

2 Apr 2020

CAS releases new open access COVID-19 Antiviral Candidate Compounds Dataset

CAS, a division of the American Chemical Society specializing in scientific information solutions, is partnering with research and technology organizations worldwide to tackle the complex challenges presented by COVID-19.

2 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

Study looks at Russian trolls that polarize vaccination efforts

There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.

2 Apr 2020

Vaccine News and Research

Latest Vaccine News and Research

Study: One-third of younger people in São José do Rio Preto lack antibodies against measles

Research reveals a potential 'chink in the armor' of SARS-CoV-2

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Scientist proposes geroprotective strategies to reduce lethality of COVID-19 in the elderly

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

‘You pray that you got the drug.’ Ailing couple gambles on trial for COVID-19 cure

Antibody recovered from SARS survivor reveals potential vulnerability of new coronavirus

Deaths of Chinese children, adolescents from infectious diseases prior to COVID-19 found to be rare

South Australian researchers make rapid progress in developing a COVID-19 vaccine

First genome sequences of SARS-CoV-2 viruses in Austria openly available

Australian scientists identify possible coronavirus drug

St George's, University of London focuses entire research on tackling coronavirus

Robots can play a major role in COVID-19 battle

Bayreuth expert presents reliable coronavirus analyses through data assimilation

Scientists find important clues to vaccine in SARS-CoV-2 genome

Promising vaccine patch candidate for COVID-19

CAS releases new open access COVID-19 Antiviral Candidate Compounds Dataset

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

Study looks at Russian trolls that polarize vaccination efforts

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in